Sucralfate Oral Suspension — Class II drug recall D-0749-2022
Terminated recall by DASH Pharmaceuticals LLC, reported 2022-04-13, distributed nationwide. Labeling: Label Mix-Up
| Recall number | D-0749-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | DASH Pharmaceuticals LLC, Upper Saddle River, NJ, United States |
| Recall initiated | 2022-03-11 |
| Classified | 2022-04-06 |
| Reported by FDA | 2022-04-13 |
| Terminated | 2023-02-16 |
| Distributed | Nationwide (US) |
| Quantity | 45,940 units |
| Reason classes | labeling |
| NDC | 69339-0148-17, 69339-0148-19 |
| Expiration dates | 2023-02-28 |
Product
Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458.
Reason for recall
Labeling: Label Mix-Up
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0749-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.